F10 F19
Conditions
Interventions
Group 1: Intervention group:
App-based training accompanied by weekly telecoaching and consisting of 14 skills. The app provides psychoeducation via texts, videos, and audio files and sets a strong fo
Sponsors
Lehrstuhl für Klinische Psychologie und Psychotherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Not less than 18 years old; Diagnosis of alcohol use disorder according to the Structured Clinical Interview for DSM-V (SCID-5-CV); Undergoing inpatient detoxification; Smartphone with android version 5 or higher; Valid email address; Written consent after informing
Exclusion criteria
Exclusion criteria: Acute suicidality assessed by the respective item of the Patient Health Questionnaire (PHQ-9); Self-reported diagnosed schizophrenia or a psychosis lasting longer than 4 weeks (lifetime); Seamless transferral to a preplanned post-acute inpatient treatment (e.g. medical rehabilitation); Legal resolution exceeding hospitalization; Linguistic or neurocognitive barriers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse risk after 6 months, assessed by the Alcohol Timeline Followback (TLFB) in clinical interviews | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychopathology: Relapse (yes/no) (TLFB; t1, t3.1, t4, t5; adapted at t3.1 and t4); Diagnosis of AUD (SCID-5-CV; t0, t5; measurement at t5 refers to the period of the last 6 months); Severity of AUD (SESA; t1, t5; adapted at t5); Severity of AUD (AUDIT; t1, t3.1, t4, t5); Craving (OCDS-G short form; t1, t2, t3.1, t4, t5); Depression symptom severity (PHQ-9; t0, t2, t3.1, t4, t5); General anxiety disorder symptom severity (GAD-7; t0, t2, t3.1, t4, t5); Quality of sleep (PSQI; t0, t2, t3.1, t4, t5; only one item) Uptake of aftercare: Uptake of aftercare programs (own development; t2, t3.2, t4, t5); Motivation for uptake of aftercare (TEQ-9; t3.2) Quality of life: Well-being (WHO-5; t1, t3.1, t5); Quality of life (EQ-5D; t1, t3.1, t4, t5); Intervention-related*: Therapeutic alliance (WAI; t3.2); Reasons of dropout (own development; t3.2); Subjective training intensity (own development; t3.2); Supportive Accountability (SA; t2, t3.2); Treatment utility (own development; t2, t3.2); Treatment satisfaction (CSQ-8; t3.2); System usability (SUS; t3.2); Treatment credibility and expectancy (CEQ; t1, t3.2); Negative Effects (NEQ; t3.2) Other: Health care service utility and productivity loss (TiC-P; t1, t4, t5); Mindfulness (MAAS; t1, t2, t3.1, t4); Emotional regulation skills (SEK-27; t1, t2, t3.1, t4); Substance recovery (SURE; t1, t3.1, t5); Impulsivity (BIS-15; t1, t2, t3.1, t4); Self-efficacy (GSE; t1, t2, t4); t0 = Screening, prior to study inclusion t1 = Baseline t2 = Mid-intervention assessment (3 weeks after randomization) t3.1 = Post outcome assessment (6 weeks after randomization) t3.2 = Post intervention-related assessment (6 weeks after randomization) t4 = 3-month follow-up assessment (3 months after randomization) t5 = 6-month follow-up assessment (6 months after randomization) *Only intervention group | — |
Countries
Germany
Contacts
Public ContactKiona Weisel
Universität Erlangen-Nürnberg, Lehrstuhl für Klinische Psychologie und Psychotherapie
Outcome results
None listed